Ho Chi Minh City (VNA) – Viatris in Vietnam, a part of a global healthcare company Viatris (Nasdaq: VTRS), in collaboration with leading medical associations, organised the scientific conference series “Advancing Non-Communicable Disease Management In The New Era – A 5-Year Journey Driving Patient Outcomes,” held in Ho Chi Minh City on June 14 and in Hanoi on June 27.
The programme brought together more than 800 doctors attending in person and approximately 1,000 healthcare professionals participating virtually nationwide, creating a large-scale scientific platform to share the latest medical advances, exchange clinical experience, and discuss solutions to enhance the management of non-communicable diseases in Vietnam.
According to the World Health Organisation (WHO), non-communicable diseases (NCDs), including cardiovascular, diabetes, cancer, and chronic respiratory diseases, account for nearly 80% of all deaths in Vietnam, making them one of the country's most pressing healthcare challenges. Against the backdrop of an aging population and the growing prevalence of metabolic risk factors, strengthening capabilities in the prevention, diagnosis, and long-term management of chronic diseases has become increasingly important for the healthcare system.
Managing non-communicable diseases in the new era
With the participation of leading experts, the conference series provided updates on emerging trends in NCDs management based on international clinical treatment guidelines, focusing on cardiovascular event prevention, risk management in patients with diabetes, neuropathic pain treatment, and mental health care. The scientific sessions highlighted the importance of early intervention, personalised treatment, comprehensive care, and multidisciplinary collaboration in optimising long-term disease management, reducing complications, and improving patients’ quality of life.
Prof. Nguyen Lan Viet, MD, PhD, Permanent Vice President of the Vietnam National Heart Association, commented: "Continuous updates on medical advances and new treatment recommendations through multidisciplinary scientific forums play an important role in fostering scientific exchange, sharing practical experience, and supporting healthcare professionals in improving patient care."
As part of the conference programme, a session on technology transfer highlighted that the treatment of non-communicable diseases is a long-term journey that requires sustainable and continuous access to high-quality medicines.
As Vietnam continues to strengthen its legal framework and manufacturing capabilities in accordance with international standards, Mr. Le Ngoc Danh, M.Pharm., Head of the Pharmaceutical Affairs Division, Ho Chi Minh City Department of Health, stated: "Technology transfer presents a promising approach for Vietnam, not only to expand manufacturing capacity, but also to progressively elevate the position of the pharmaceutical industry within the regional value chain. Through coordinated collaboration among regulatory authorities, domestic manufacturers, and multinational pharmaceutical companies, these projects can contribute to maintaining a stable supply of high-quality medicines, particularly for diseases requiring long-term treatment."
A five-year journey alongside Vietnam’s healthcare community
This year’s conference series carries special significance as it marks five years since Viatris established its presence and began operations in Vietnam. Throughout this journey, Viatris has partnered with the medical community through scientific exchange initiatives, continuing medical education programs, and professional collaborations aimed at enhancing long-term disease management and improving patients’ quality of life.
In addition to scientific and professional collaborations, the technology transfer project for selected originator medicines represents one of Viatris’ strategic milestones in Vietnam. To date, the first products under the project have received marketing authorisation from the Ministry of Health and are expected to support treatment needs in the coming time.
This initiative not only contributes to strengthening local pharmaceutical manufacturing capabilities in accordance with rigorous international standards but also expands patient access to high-quality treatment options.
Ms. Radhika Bhalla, Head of Viatris Vietnam and Asia Alliance Markets, shared: "This year’s scientific conference series marks an important milestone in Viatris’ five-year journey alongside Vietnam’s healthcare community and reinforces the value of multi-stakeholder collaboration in addressing non-communicable diseases. We remain committed to being a trusted partner to the medical community through scientific initiatives, professional collaboration, and efforts to expand access to treatment, helping improve healthcare outcomes for people across Vietnam."/.
Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we’re developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We’re purpose-built to make an impact with a dynamic portfolio that spans generics, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai, China, and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube, and X.
In Vietnam, Viatris’ broad portfolio includes cardiovascular disease, pain, central nervous system, and men’s health, with a continued focus on localization efforts through technology transfer of originators.
